FOSTER CITY, Calif — A group of severely ill coronavirus patients improved and even went home after receiving an experimental antiviral drug, STAT News reported Thursday after it received a video of a conversation about the trial.
The Gilead Sciences drug, remdesivir, has shown promise against other coronaviruses in the past and in lab tests against the one causing the current pandemic, which now has claimed more than 140,000 lives worldwide.
No drugs are approved for treating the disease yet, but at least five large studies are testing remdesivir. The company also has given it to more than 1,700 patients on a case-by-case emergency basis.
The University of Chicago Medicine, according to STAT, recruited 125 people with COVID-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had